Fentanyl Transdermal System
Product Images NDC 42254-002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Fentanyl Transdermal System (NDC 42254-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (A7c456e6 403b 4aae A576 60b106bf66a7 01)

FDA Label Image

Patch Illustration (A7c456e6 403b 4aae A576 60b106bf66a7 02)

Patch Illustration (A7c456e6 403b 4aae A576 60b106bf66a7 02)
This appears to be a diagram or image with labels of layers in a transdermal patch design. It includes a backing film, rate controlling membrane, drug containing layer, skin adhesive layer, and protective liner. No other information is available.*
FDA Label Image

Serum Fentanyl Concentrations (A7c456e6 403b 4aae A576 60b106bf66a7 03)

Serum Fentanyl Concentrations (A7c456e6 403b 4aae A576 60b106bf66a7 03)
This is a study of ten individuals measuring the concentration of serum fentanyl after multiple applications of a fentanyl transdermal system (100 mcg/hr). The results are presented in a graph, showing the concentrations of fentanyl over a period of 19 days. There were repeated 72-hour applications as well as single 72-hour applications, with the concentration measured after the system was removed.*
FDA Label Image

Patch Illustration (A7c456e6 403b 4aae A576 60b106bf66a7 04)

Patch Illustration (A7c456e6 403b 4aae A576 60b106bf66a7 04)
This is a label of a transdermal patch. The patch consists of a backing film, a rate-controlling membrane, a drug-containing layer, skin adhesive layer, and a protective liner. The purpose of a transdermal patch is to administer medication in a controlled manner through the skin.*
FDA Label Image

Figure 1 (Patch applied to chest)

FDA Label Image

Figure 2 (Patch applied to back)

FDA Label Image

Figure 3 (Patch applied to side)

FDA Label Image

Figure 4 (Patch applied to shoulder)

FDA Label Image

Figure 1 (Patch applied to chest)

FDA Label Image

Figure 2 (Patch applied to back)

FDA Label Image

Figure 3 (Patch applied to side)

FDA Label Image

Figure 4 (Patch applied to shoulder)

FDA Label Image

Figure 5 (Trimming chest hair)

FDA Label Image

Figure 6 (Tearing open a pouch)

FDA Label Image

Figure 7 (Peeling the liner)

FDA Label Image

Figure 8 (Applying patch to chest)

FDA Label Image

Figure 9 (Folding patch)

FDA Label Image

Figure 10 (Flushing patch down a toilet)

FDA Label Image

Fentanyl Transdermal System 50mcg/hr (A7c456e6 403b 4aae A576 60b106bf66a7 19)

Fentanyl Transdermal System 50mcg/hr (A7c456e6 403b 4aae A576 60b106bf66a7 19)
This is a description of a medication product called Fentanyl Transdermal System 50mcg/hr. Each transdermal system contains 50mcg/hr of fentanyl and is meant for use over a period of 72 hours. The package includes one transdermal system and its product ID is SF000205. The product is distributed by Physician Partner and should be stored at a controlled room temperature of 15°-30°C. The medication should be kept out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.